Cargando…
Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma
Osteosarcoma (OS) is the primary bone tumor in children and young adults. Currently, there are no reliable, noninvasive biologic markers to detect the presence or progression of disease, assess therapy response, or provide upfront prognostic insights. MicroRNAs (miRNAs) are evolutionarily conserved,...
Autores principales: | Allen-Rhoades, Wendy, Kurenbekova, Lyazat, Satterfield, Laura, Parikh, Neha, Fuja, Daniel, Shuck, Ryan L, Rainusso, Nino, Trucco, Matteo, Barkauskas, Donald A, Jo, Eunji, Ahern, Charlotte, Hilsenbeck, Susan, Donehower, Lawrence A, Yustein, Jason T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529336/ https://www.ncbi.nlm.nih.gov/pubmed/25784290 http://dx.doi.org/10.1002/cam4.438 |
Ejemplares similares
-
Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential
por: Techavichit, Piti, et al.
Publicado: (2016) -
Metabolic modulation of Ewing sarcoma cells inhibits tumor growth and stem cell properties
por: Dasgupta, Atreyi, et al.
Publicado: (2017) -
MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophages in osteosarcoma
por: Nirala, Bikesh K., et al.
Publicado: (2023) -
Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis
por: Roos, Alison, et al.
Publicado: (2015) -
K-Ras and p53 mouse model with molecular characteristics of human rhabdomyosarcoma and translational applications
por: Nakahata, Kengo, et al.
Publicado: (2022)